• Exchange: Copenhagen
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Bavarian Nordic A/S

+ Add to Watchlist

BAVA:DC

215.0000 DKK 4.5000 2.14%

As of 11:02:37 ET on 01/26/2015.

Snapshot for Bavarian Nordic A/S (BAVA)

Open: 210.0000 Day's Range: 209.5000 - 215.0000 Volume: 99,260
Previous Close: 210.5000 52wk Range: 91.0000 - 220.0000 1-Yr Rtn: +112.87%

Stock Chart for BAVA

No chart data available.
  • BAVA:DC 215.0000
  • 1D
  • 1M
  • 1Y
210.5000
Interactive BAVA Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for BAVA

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) 111.8045
Relative P/E vs. KFX -
Earnings Per Share (DKK) (ttm) -3.7854
Est. EPS (DKK) (12/2014) 1.9230
Est. PEG Ratio -
Market Cap (M DKK) 5,949.32
Shares Outstanding (M) 27.67
30 Day Average Volume 118,189
Price/Book (mrq) 6.3734
Price/Sale (ttm) 5.5856
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 03/11/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for BAVA

  • Revenue
  • Net Income (M/DKK)
  • Profit Margin (%)

Company Profile & Key Executives for BAVA

Bavarian Nordic A/S is a biotechnology company developing and producing vaccines for the treatment and prevention of cancer and infectious diseases. The company also manufactures and delivers modern smallpox vaccines for governments under national emergency rules.

Gerard W M Van OdijkChairmanPaul ChaplinPresident/CEO
James B Breitmeyer "Jim"Pres:Cancer/Exec VPOle LarsenExec VP/CFO
More Company Profile & Key Executives for BAVA

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil